Dermata Therapeutics logo

Dermata Therapeutics Share Price (NASDAQ: DRMA)

$5.64

0.29

(5.42%)

Last updated on

Check the interactive Dermata Therapeutics Stock chart to analyse performance

Dermata Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.37
    Today's High:$5.64

    Day's Volatility :4.79%

  • 52 Weeks Low:$5.09
    52 Weeks High:$24.90

    52 Weeks Volatility :79.56%

Dermata Therapeutics Stock Returns

PeriodDermata Therapeutics IncIndex (Russel 2000)
3 Months
-22.14%
0.0%
6 Months
-52.19%
0.0%
1 Year
-65.94%
0.0%
3 Years
-99.62%
-4.7%

Dermata Therapeutics Inc Key Stats

Check Dermata Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.35
Open
$5.38
Today's High
$5.64
Today's Low
$5.37
Market Capitalization
$3.6M
Today's Volume
$27.0K
52 Week High
$24.9
52 Week Low
$5.09
Revenue TTM
$0.0
EBITDA
$-7.9M
Earnings Per Share (EPS)
$20.96
PE Ratio
0.26
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-231.27%

Stock Returns calculator for Dermata Therapeutics Stock including INR - Dollar returns

The Dermata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dermata Therapeutics investment value today

Current value as on today

₹40,534

Returns

₹59,466

(-59.47%)

Returns from Dermata Therapeutics Stock

₹64,750 (-64.75%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Dermata Therapeutics Stock

10%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Dermata Therapeutics Stock from India on INDmoney has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dermata Therapeutics Inc

  • Name

    Holdings %

  • UBS Group AG

    1.10%

  • Geode Capital Management, LLC

    0.32%

  • JONES FINANCIAL COMPANIES LLLP

    0.19%

  • Tower Research Capital LLC

    0.08%

  • Wells Fargo & Co

    0.03%

  • SBI Securities Co Ltd

    0.02%

Analyst Recommendation on Dermata Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Dermata Therapeutics(by analysts ranked 0 to 5 stars)

Dermata Therapeutics Share Price Target

What analysts predicted

Upside of 77.3%

Target:

$10.00

Current:

$5.64

Dermata Therapeutics share price target is $10.00, a slight Upside of 77.3% compared to current price of $5.64 as per analysts' prediction.

Dermata Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, DRMA stock has moved down by -24.3%
  • DRMA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 138.6%
  • DRMA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.2%

Dermata Therapeutics Technicals Summary

Sell

Neutral

Buy

Dermata Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Dermata Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Dermata Therapeutics Inc logo
-12.55%
-52.19%
-65.94%
-99.62%
-99.96%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Dermata Therapeutics Inc

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Organization
Dermata Therapeutics
Employees
8
CEO
Mr. Gerald T. Proehl
Industry
Miscellaneous

Key Management of Dermata Therapeutics Inc

NameTitle
Mr. Gerald T. Proehl
Founder, President, CEO & Chairman
Mr. David F. Hale
Co-Founder & Lead Independent Director
Ms. Kyri K. Van Hoose CPA, M.B.A.
Senior VP & CFO
Dr. Christopher J. Nardo M.P.H., Ph.D.
Senior VP & Chief Development Officer
Mr. Sean Proehl
Associate General Counsel
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in DRMA Stock from India :

What is Dermata Therapeutics share price today?

Dermata Therapeutics share price today is $5.64 as on at the close of the market. Dermata Therapeutics share today touched a day high of $5.64 and a low of $5.37.

What is the 52 week high and 52 week low for Dermata Therapeutics share?

Dermata Therapeutics share touched a 52 week high of $24.90 and a 52 week low of $5.09. Dermata Therapeutics stock price today i.e. is closed at $5.64, lower by 77.35% versus the 52 week high.

How to invest in Dermata Therapeutics Stock (DRMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dermata Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dermata Therapeutics Shares that will get you 0.2660 shares as per Dermata Therapeutics share price of $5.64 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Dermata Therapeutics Stock (DRMA) from India?

Indian investors can start investing in Dermata Therapeutics (DRMA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Dermata Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Dermata Therapeutics share’s latest price of $5.64 as on August 30, 2025 at 1:29 am IST, you will get 1.7730 shares of Dermata Therapeutics. Learn more about fractional shares .

What are the returns that Dermata Therapeutics has given to Indian investors in the last 5 years?

Dermata Therapeutics stock has given -99.96% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?